SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-313980
Filing Date
2017-10-19
Accepted
2017-10-19 16:37:59
Documents
8
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 20-F d457374d20f.htm 20-F 1858752
2 EX-4.2 d457374dex42.htm EX-4.2 100424
3 EX-12.1 d457374dex121.htm EX-12.1 9324
4 EX-13.1 d457374dex131.htm EX-13.1 4338
5 EX-15.1 d457374dex151.htm EX-15.1 2163
6 GRAPHIC g457374fin_pg02.jpg GRAPHIC 5982
7 GRAPHIC g457374g1019121805611.jpg GRAPHIC 4609
8 GRAPHIC g457374g1019122007666.jpg GRAPHIC 1988
  Complete submission text file 0001193125-17-313980.txt   1993801
Mailing Address LEVEL 12, 95 PITT STREET SYDNEY, NEW SOUTH WALES C3 2000
Business Address LEVEL 12, 95 PITT STREET SYDNEY, NEW SOUTH WALES C3 2000 612 9276 1224
Prima BioMed Ltd (Filer) CIK: 0001506184 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-35428 | Film No.: 171145072
SIC: 2834 Pharmaceutical Preparations